Efficacy of combined photodynamic therapy and sub-Tenon's capsule injection of triamcinolone acetonide for age-related macular degeneration

Journal of Medical Investigation

Volumn 56, Issue 3-4, 2009, Pages 116-119

  Kamote, Takashi ^a   Naito, Takeshi ^a   Nagasawa, Toshihiko ^a   Shiota, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Age related macular degeneration; Combination therapy; Photodynamic therapy; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG EFFICACY; ENDOPHTHALMITIS; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 70350007788     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.56.116     Document Type: Article

References (12)

1. Bressler NM: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 119: 198-207, 2001
2. Verteporfin In Photodynamic Therapy Study Group: Verteporfin in Photodynamic Therapy Report 2. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial inkling lesions with occult with no classic choroidal neovascularisation. Am J Ophthalmol 131: 541-560, 2001
3. Ranson NT, Danis RP, Ciulla TA, Pratt L: Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol 86: 527-529, 2002
4. Folkman J, Ingber DE: Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206: 374-383, 1987
5. Augustin AJ, Schmidt-Erfurth U: Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration. Eur J Ophthalmol 16: 824-834, 2006
6. Augustin AJ, Schmidt-Erfurth U: Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 141: 638-645, 2006
7. Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS: Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol 90: 337-341, 2006
8. Spaide RF, Sorenson J, Maranan L: Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 1517-1525, 2003
9. Van de Moere A, Sandhu SS, Kak R, Mitchell KW, Talks SJ: Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology 112: 1896-1903, 2005
10. Japanese Age-Related Macular Degeneration Trial (JAT) Study Group: Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 136: 1049-1461, 2003
11. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW: Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106: 1915-23, 1999
12. Rechtman E, Danis RP, Pratt LM, Harris A: Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 88: 344-347, 2004